Administration of the glial cell modulator, minocycline, in the nucleus accumbens attenuated the maintenance and reinstatement of morphine-seeking behavior

Canadian Journal of Physiology and Pharmacology

Volumn 94, Issue 3, 2015, Pages 257-264

  Arezoomandan, Reza ^a   Haghparast, Abbas ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Conditioned place preference; Minocycline; Morphine maintenance; Nucleus accumbens; Reinstatement

Indexed keywords

MINOCYCLINE; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONDITIONED PLACE PREFERENCE TEST; CONTROLLED STUDY; DRUG EFFECT; DRUG SEEKING BEHAVIOR; GLIA; MALE; MORPHINE ADDICTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RELAPSE; ANIMAL; DRUG EFFECTS; MORPHINE DEPENDENCE; SUBSTANCE-RELATED DISORDERS; WISTAR RAT;

ANIMALS; MALE; MINOCYCLINE; MORPHINE; MORPHINE DEPENDENCE; NEUROGLIA; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; SUBSTANCE-RELATED DISORDERS;

EID: 84959350678     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2015-0209     Document Type: Article

References (39)

1. Aguilar, M.A., Rodriguez-Arias, M., and Minarro, J. 2009. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res. Rev. 59(2): 253–277. doi:10.1016/j.brainresrev.2008.08.002.
2. Attarzadeh-Yazdi, G., Arezoomandan, R., and Haghparast, A. 2014. Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat. Prog. Neuropsychopharmacol. Biol. Psychiatry, 53: 142–148. doi:10.1016/j.pnpbp.2014.04.008.
3. Benarroch, E.E. 2005. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin Proc. 80: 1326–1338. doi:10.4065/80.10.1326.
4. Chen, M., Ona, V.O., Li, M., Ferrante, R.J., Fink, K.B., Zhu, S., et al. 2000. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med. 6: 797–801. doi:10.1038/77528.
5. Chen, X., Ma, L., Jiang, Y., Chen, S., Zhu, C., Liu, M., et al. 2012. Minocycline up-regulates the expression of brain-derived neurotrophic factor and nerve growth factor in experimental autoimmune encephalomyelitis. Eur. J. Pharmacol. 686(1): 124–129. doi:10.1016/j.ejphar.2012.04.043.
6. Cooper, Z.D., Jones, J.D., and Comer, S.D. 2012. Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances. Expert. Opin. Investig. Drugs, 21(2): 169–178. doi:10.1517/13543784.2012.651123.
7. Cui, Y., Liao, X.X., Liu, W., Guo, R.X., Wu, Z.Z., Zhao, C.M., et al. 2008. A novel role of minocycline: Attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain Behav. Immun. 22(1): 114–123. doi:10.1016/j.bbi.2007.07.014.
8. Fujita, Y., Kunitachi, S., Iyo, M., and Hashimoto, K. 2012. The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice. Pharmacol. Biochem. Behav. 101(2): 303–306. doi:10.1016/j.pbb.2012.01.005.
9. Garrido, E., Perez-Garcia, C., Alguacil, L.F., and Diez-Fernandez, C. 2005. The 2 adrenoceptor antagonist yohimbine reduces glial fibrillary acidic protein upregulation induced by chronic morphine administration. Neurosci. Lett. 383(1): 141–144. doi:10.1016/j.neulet.2005.04.002.
10. Gonzalez, J.C., Egea, J., Del Carmen Godino, M., Fernandez-Gomez, F.J., Sanchez-Prieto, J., Gandia, L., et al. 2007. Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca2+ signalling in hippocampal neurons. Eur. J. Neurosci. 26(9): 2481–2495. doi:10.1111/j.1460-9568.2007.05873.x.
11. Hashimoto, K., Tsukada, H., Nishiyama, S., Fukumoto, D., Kakiuchi, T., and Iyo, M. 2007. Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a PET study in conscious monkeys. Biol. Psychiatry, 61(5): 577–581. doi:10.1016/j.biopsych.2006.03.019.
12. Hutchinson, M.R., Northcutt, A.L., Chao, L.W., Kearney, J.J., Zhang, Y., Berkelhammer, D.L., et al. 2008. Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia. Brain Behav. Immun. 22(8): 1248–1256. doi:10.1016/j.bbi.2008.07.008.
13. Hutchinson, M.R., Lewis, S.S., Coats, B.D., Skyba, D.A., Crysdale, N.Y., Berkelhammer, D.L., et al. 2009. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic av411 (ibudilast). Brain Behav. Immun. 23(2): 240–250. doi:10.1016/j.bbi.2008.09.012.
14. Kim, S.U., and de Vellis, J. 2005. Microglia in health and disease. J. Neurosci. Res. 81(3): 302–313. doi:10.1002/jnr.20562.
15. Lee, S.M., Yune, T.Y., Kim, S.J., Kim, Y.C., Oh, Y.J., Markelonis, G.J., et al. 2004. Minocycline inhibits apoptotic cell death via attenuation of TNF-α expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures. J. Neurochem. 91(3): 568–578. doi:10.1111/j.1471-4159.2004.02780.x.
16. Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S., and Collins, F. 1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260(5111): 1130–1132. doi:10.1126/science.8493557.
17. Manzanedo, C., Aguilar, M.A., Do Couto, B.R., Rodriguez-Arias, M., and Minarro, J. 2009. Involvement of nitric oxide synthesis in sensitization to the rewarding effects of morphine. Neurosci. Lett. 464(1): 67–70. doi:10.1016/j.neulet.2009.08.017.
18. Miguel-Hidalgo, J.J. 2009. The role of glial cells in drug abuse. Curr. Drug Abuse Rev. 2(1): 76. doi:10.2174/1874473710902010076.
19. Mika, J., Wawrzczak-Bargiela, A., Osikowicz, M., Makuch, W., and Przewlocka, B. 2009. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. Brain Behav. Immun. 23(1): 75–84. doi:10.1016/j.bbi.2008.07.005.
20. Narita, M., Miyatake, M., Narita, M., Shibasaki, M., Shindo, K., Nakamura, A., et al. 2006. Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse. Neuropsychopharmacology, 31(11): 2476–2488. doi:10.1038/sj.npp.1301007.
21. National Institutes of Health. 1996. NIH Publications No. 80-23.
22. Niwa, M., Nitta, A., Yamada, K., and Nabeshima, T. 2007. The Roles of Glial Cell Line-Derived Neurotrophic Factor, Tumor Necrosis Factor-alpha, and an Inducer of These Factors in Drug Dependence. J. Pharmacol. Sci. 104(2): 116–121. doi:10.1254/jphs.CP0070017.
23. Paxinos, G., and Watson, C. 2006. The rat brain in stereotaxic coordinates, hard cover edition. Academic Press, 62–65.
24. Pennartz, C., Groenewegen, H.J., and Lopes da Silva, F.H. 1994. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog. Neurobiol. 42(6): 719–761. doi:10.1016/0301-0082(94)90025-6.
25. Robinson, T.E., and Kolb, B. 1999. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11(5): 1598–1604. doi:10.1046/j.1460-9568.1999.00576.x.
26. Sakata, H., Niizuma, K., Yoshioka, A., Kim, G.S., Jung, J.E., Katsu, M., et al. 2012. Minocycline-Preconditioned Neural Stem Cells Enhance Neuroprotection after Ischemic Stroke in Rats. J. Neurosci. 32(10): 3462–3473. doi:10.1523/JNEUROSCI.5686-11.2012.
27. Seabrook, T.J., Jiang, L., Maier, M., and Lemere, C.A. 2006. Minocycline Affects Microglia Activation, Ab Deposition, and Behavior in APP-tg Mice. Glia, 53(7): 776–782. doi:10.1002/glia.20338.
28. Sofuoglu, M., Mooney, M., Kosten, T., Waters, A., and Hashimoto, K. 2011. Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. Psychopharmacology, 213: 61–68. doi:10.1007/s00213-010-2014-5.
29. Suk, K. 2004. Minocycline suppresses hypoxic activation of rodent microglia in culture. Neurosci. Lett. 366: 167–171. doi:10.1016/j.neulet.2004.05.038.
30. Tikka, T.M., and Koistinaho, J.E. 2001. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 166(12): 7527–7533. doi:10.4049/jimmunol.166.12.7527.
31. Tikka, T., Fiebich, B.L., Goldsteins, G., Keinanen, R., and Koistinaho, J. 2001a. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21(8): 2580–2588.
32. Tikka, T., Usenius, T., Tenhunen, M., Keinanen, R., and Koistinaho, J. 2001b. Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation. J. Neurochem.78(6): 1409–1414. doi:10.1046/j.1471-4159.2001.00543.x.
33. Van Ree, J.M., Gerrits, M.A., and Vanderschuren, L.J. 1999. Opioids, reward and addiction: An encounter of biology, psychology, and medicine. Pharmacol. Rev. 51(2): 341–396.
34. Wang, X., Zhu, S., Drozda, M., Zhang, W., Stavrovskaya, I.G., Cattaneo, E., et al. 2003. Minocycline inhibits caspase-independent and-dependent mitochondrial cell death pathways in models of Huntington’s disease. Proc. Natl. Acad. Sci. U.S.A. 100: 10483–10487. doi:10.1073/pnas.1832501100.
35. Yirmiya, R., and Goshen, I. 2011. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 25(2): 181–213. doi: 10.1016/j.bbi.2010.10.015.
36. Yong, V.W., Wells, J., Giuliani, F., Casha, S., Power, C., and Metz, L.M. 2004. The promise of minocycline in neurology. Lancet Neurol. 3(12): 744–751. doi:10. 1016/S1474-4422(04)00937-8.
37. Zhang, L., Kitaichi, K., Fujimoto, Y., Nakayama, H., Shimizu, E., Iyo, M., et al. 2006. Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine. Prog. Neuropsychopharmacol. Biol. Psychiatry, 30(8): 1381–1393. doi:10.1016/j.pnpbp.2006.05.015.
38. Zhang, X.-Q., Cui, Y., Cui, Y., Chen, Y., Na, X.-D., Chen, F.-Y., et al. 2012. Activation of p38 signaling in the microglia in the nucleus accumbens contributes to the acquisition and maintenance of morphine-induced conditioned place preference. Brain Behav. Immun. 26(2): 318–325. doi:10.1016/j.bbi.2011.09.017.
39. Zhu, S., Stavrovskaya, I.G., Drozda, M., Kim, B.Y., Ona, V., Li, M., et al. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature, 417(6884) 74–78. doi:10.1038/417074a.